Innate Pharma (IPHA) Q1 2024 Earnings

21MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q1 2024
-0.45
-0.3
-0.15
0

Details

Expected EPS
-0.44517476542
Actual EPS
-0.1324488
Surprise EPS
0.31
Surprise Percent
+70.25%

Description

Innate Pharma (IPHA) has reported earnings of -0.1324488 per share for Q1 2024.

0 Comments

Share your thoughts